Effect of CoQ10 on serum levels of LPPLA2, troponin, and creatinine kinase-MB. by Yousif Jameel Jbrael (17797560)

The effect of p20 on the composition of <i>GFP</i> siRNAs. by Yongle Zhang (11355546)

Data_Sheet_1_Growth of freshwater cyanobacterium Aphanizomenon sp. ULC602 in different growing and nutrient conditions.docx by Mai-Lan Pham (17686353)

“…Moreover, a decrease in Chlo-a biomass was observed under sulfur deficiency. …”

Human mesenchymal stem/stromal cells (hMSCs) increased <i>Ccl2</i> expression and reduced inflammatory responses. by Kazumichi Yagura (4537504)

“…The gene expression levels are expressed the relative level (fold) to compare with pod 0 (basal level, n = 6 mouse) after normalization against <i>Gapdh</i> as a housekeeping gene. …”

The spatial pattern of dengue including hotspot and coldspot in Bangladesh in 2019–2023. by Kamal Hossain (331680)

Pharmacodynamic surrogates of levonorgestrel activity. by Andrea R. Thurman (5286005)

The spatial (districtwide) distribution of census population of Bangladesh in 2022. by Kamal Hossain (331680)

Demographic and baseline characteristics treated population. by Andrea R. Thurman (5286005)

Disposition of participants. by Andrea R. Thurman (5286005)

Disruption of p20 binding to ATG8 reduces CTV-induced autophagy and reduces viral infection. by Yongle Zhang (11355546)

Summary of duration of use, total dose received and adverse events. by Andrea R. Thurman (5286005)

The spatial distribution of dengue incidence rate per million by month across districts of Bangladesh in 2023. by Kamal Hossain (331680)

The spatial distribution of dengue incidence rate per million by month across districts of Bangladesh in 2022. by Kamal Hossain (331680)

p24 antigen production from ectocervical and vaginal tissue biopsies. by Andrea R. Thurman (5286005)

The spatial distribution of districtwide dengue cases and dengue incidence rate (DIR) per million in Bangladesh in 2019–2023. by Kamal Hossain (331680)

Comparison of independent group soluble proteins at end of treatment. by Andrea R. Thurman (5286005)

<i>CDKN3</i> mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer by Eira Valeria Barrón (796117)

“…A total of 68.2% of CC patients over expressing <i>CDKN3</i> gene (fold change ≥ 17) died within two years of diagnosis, independent of the clinical stage and HPV type (Hazard Ratio = 5.0, 95% CI: 2.5–10, p = 3.3 x 10⁻⁶, Cox proportional-hazards regression). …”

<i>In vitro</i> HIV inhibitory activity of the CVL supernatant for each treatment and dosing regimen. by Andrea R. Thurman (5286005)

Immune cells in ectocervical tissue at the end of treatment (visit 31) based on treatment and dosing assignment. by Andrea R. Thurman (5286005)

Oxygraphy protocols. by Aleksey V. Zholobenko (4491667)